Trial Profile
Pilot, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study, to Evaluate the Tolerability and Safety of FXFM244 Antibiotic Foam and to Monitor Its Clinical Effect in Moderate to Severe Rosacea Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 May 2021
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Foamix; VYNE Therapeutics
- 04 Dec 2014 New trial record